When cardiovascular complications occur in young patients with type 1 diabetes mellitus and how should we demonstrate it? by Mehmet Eyuboglu
Acta Clin Croat 2016; 55:515-516 Letter to the Editor
doi: 10.20471/acc.2016.55.03.25
Acta Clin Croat, Vol. 55, No. 3, 2016  515
WHEN CARDIOVASCULAR COMPLICATIONS OCCUR 
IN YOUNG PATIENTS WITH TYPE 1 DIABETES MELLITUS 
AND HOW SHOULD WE DEMONSTRATE IT?
Mehmet Eyuboglu
Correspondence to: Mehmet Eyuboglu, MD, Department of Car-
diology, Dinar State Hospital, Dinar, Afyonkarahisar, Turkey 03400
E-mail: mhmtybgl@gmail.com
Received May 19, 2015, accepted January 8, 2016
Letter to the Editor about the article: Left ventricular systolic func-
tion in selected type 1 diabetic patients with or without diabe-
tic retinopathy and microalbuminuria. Acta Clin Croat 2014;53:
383-389.
Dear Editor,
In a recent issue of your journal, I have read the ar-
ticle by Bućan et al. with great interest1. In their study, 
the authors report that there was no statistically sig-
nifi cant correlation between the duration of type 1 dia-
betes mellitus (DM) and echocardiographic values. It is 
known that DM increases the prevalence of cardiovas-
cular diseases (CVD) independently of the underlying 
coronary artery disease2. In the present study by Bućan 
et al., the mean age of study population was 33 years, 
and 43.5 years for the oldest group. In a large study that 
included 3200 patients with type 1 DM, the prevalence 
of CVD was found to be 6% in the 15-29 age group 
and 25% in the 45-59 age group. Th e prevalence of 
CVD was related to the increase in age signifi cantly3. 
Th erefore, this study population may be younger for 
cardiovascular complications of type 1 DM.
Th e relationship of hyperglycemia with microangi-
opathy as well as macroangiopathy is more signifi cant 
in type 1 DM than type 2 DM4. In the present study 
by Bućan et al., HbA1c levels were <9%. Also, patients 
with hypertension and other heart and kidney diseases 
were excluded. In this sense, this study population may 
have a low risk of CVD, especially of systolic dysfunc-
tion, which can be a complication of microangiopathy 
and macroangiopathy.
In a large study which included type 1 DM patients 
diagnosed at the age of <18 years between 1965 and 
1979, CVD was identifi ed as the leading cause of death 
in diabetes after more than 20 years of duration. In the 
fi rst 20 years of follow up, the major reasons for com-
plications were acute diabetic complications and end-
stage renal disease5. Also, in the Finnish Diabetic Ne-
phropathy study6, excess mortality was only observed in 
individuals with chronic kidney disease in type 1 DM 
patients with diabetes duration of over 20 years. Th is 
fi nding suggests that kidney damage in individuals 
with type 1 DM refl ects more generalized damage to 
the cardiovascular system leading to CVD and subse-
quently to mortality. In the present study by Bućan et 
al., the mean duration of DM was 11 years and longest 
duration of DM was 17.1 years. Hence, these durations 
may be short times to have eff ect on systolic function 
and cardiovascular damage in type 1 DM patients. A 
longer follow up period may indicate new fi ndings.
It is known that diastolic dysfunction appears before 
systolic dysfunction in CVD. Also, impaired left ven-
tricle systolic function has been demonstrated by tissue 
doppler imaging while ejection fraction is in the normal 
range7. Th erefore, to evaluate the cardiovascular eff ect of 
DM by ejection fraction only may be a wrong approach. 
It may cause to miss the early phase of CVD.
In conclusion, the analysis of this study may be im-
proved. Th is study included younger patients, short du-
ration of DM and ejection fraction as echocardiograph-
ic parameter. Longer follow up and using more sensitive 
echocardiographic parameters such as tissue doppler 
imaging may have eff ect on the results of this study.
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